bpc-157 tendon-to-bone integration Regeneration or Risk? A Narrative Review of for Musculoskeletal Healing Therapeutic Peptides in Orthopaedics: Applications,

is business development manager of LinkoCare and serves on the board of directors of LinkoCare Life Sciences AB, as an unpaid board member

Who should avoid GHK-Cu entirely Wilson's disease or any copper metabolism disorder Active malignancy until more evidence exists Pregnancy and breastfeeding Known copper sensitivity Anyone unable to maintain sterile technique for injection When unsure, talk to us before starting anything

Expect gradual improvement rather than overnight transformation

Kawashima, T., Ohkubo, K

A good part of the human trial evidence is younger and less refined than what we see in animal models, although the trends are similar

Some people notice subtle shifts in clarity and mood within a few weeks, while for others, the improvements are more gradual over a couple of months